Standardized Indices of Breathlessness

标准化呼吸困难指数

基本信息

  • 批准号:
    6879362
  • 负责人:
  • 金额:
    $ 10.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-03-01 至 2005-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): For patients with respiratory disease the symptom of breathlessness (dyspnea) is the most frequent reason for seeking medical attention. Current methods for measuring the impact of breathlessness on activities of daily living rely on face-to-face interviews conducted by health care providers. Two common measures are the Baseline Dyspnea Index representing the severity of dyspnea at a single point in time, and the Transition Dyspnea Index representing changes in dyspnea compared with the baseline level before treatment. Despite widespread acceptance of these measures, the interview technique has been criticized on three counts: (1) selection of severity of breathlessness is made by the interviewer, not the patient, and thereby can increase measurement error (2) the method cannot be applied consistently in different medical centers because the same interviewers are not employed at all test sites (3) the process is expensive due to the cost of training and employing health care providers to conduct interviews and enter data into the computer. There is a need for a less expensive, standardized approach to the measurement of dyspnea that could be applied consistently throughout the world. The long term objective of this project is to develop such a method. The major aim of Phase I is to show that a computer-administered, standardized method completed by the patient yields results equivalent to those secured by interviews. Subjects employing the new method will be 100 patients diagnosed with chronic obstructive pulmonary disease. PROPOSED COMMERCIAL APPLICATIONS. There are excellent commercial prospects for computer software that allows the patient to rate their level of dyspnea associated with activities of daily living. Once the software package is implemented and tested, site licenses for acquiring the program will be sold to clinics, hospitals, and pharmaceutical companies worldwide.
描述(申请人提供):对于呼吸系统疾病患者,呼吸困难(呼吸困难)是最常见的就医原因。目前衡量呼吸困难对日常生活活动影响的方法依赖于卫生保健提供者进行的面对面访谈。两个常见的衡量标准是代表单个时间点呼吸困难严重程度的基线呼吸困难指数和代表与治疗前基线水平相比呼吸困难变化的过渡性呼吸困难指数。尽管这些措施被广泛接受,但面谈技术在三个方面受到了批评:(1)气促严重程度的选择是由面试者而不是患者做出的,因此可能会增加测量误差(2)该方法不能在不同的医疗中心一致应用,因为不是在所有测试地点雇用相同的面试者(3)由于培训和雇用卫生保健提供者进行面谈和将数据输入计算机的成本,该过程代价高昂。需要一种成本更低、标准化的方法来测量呼吸困难,这种方法可以在世界各地一致应用。这个项目的长期目标是开发这样一种方法。第一阶段的主要目的是表明,由患者完成的计算机管理的标准化方法产生的结果与通过访谈获得的结果相同。使用新方法的受试者将是100名被诊断为慢性阻塞性肺疾病的患者。建议的商业应用。计算机软件有很好的商业前景,它允许患者评估他们与日常生活活动相关的呼吸困难水平。一旦该软件包被实施和测试,获取该程序的站点许可证将被出售给世界各地的诊所、医院和制药公司。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN C BAIRD其他文献

JOHN C BAIRD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN C BAIRD', 18)}}的其他基金

Three-Dimensional Pain Mapping
三维疼痛图
  • 批准号:
    7600742
  • 财政年份:
    2009
  • 资助金额:
    $ 10.66万
  • 项目类别:
Children's Computer Assessment of Pain and Mood
儿童疼痛和情绪的计算机评估
  • 批准号:
    7896624
  • 财政年份:
    2006
  • 资助金额:
    $ 10.66万
  • 项目类别:
Children's Computer Assessment of Pain
儿童计算机疼痛评估
  • 批准号:
    7157950
  • 财政年份:
    2006
  • 资助金额:
    $ 10.66万
  • 项目类别:
Standardized Indices of Breathlessness
标准化呼吸困难指数
  • 批准号:
    7283602
  • 财政年份:
    2004
  • 资助金额:
    $ 10.66万
  • 项目类别:
Standardized Indices of Breathlessness
标准化呼吸困难指数
  • 批准号:
    7158099
  • 财政年份:
    2004
  • 资助金额:
    $ 10.66万
  • 项目类别:
Dynamic Assessment of Hearing Aids
助听器的动态评估
  • 批准号:
    7108104
  • 财政年份:
    2002
  • 资助金额:
    $ 10.66万
  • 项目类别:
Dynamic Assessment of Hearing Aids
助听器的动态评估
  • 批准号:
    7204180
  • 财政年份:
    2002
  • 资助金额:
    $ 10.66万
  • 项目类别:
Dynamic Assessment of Hearing Aids
助听器的动态评估
  • 批准号:
    6551439
  • 财政年份:
    2002
  • 资助金额:
    $ 10.66万
  • 项目类别:
Continuous Measurement of Breathlessness
连续测量呼吸困难
  • 批准号:
    6585727
  • 财政年份:
    2001
  • 资助金额:
    $ 10.66万
  • 项目类别:
Computer Assessment of Pain
计算机疼痛评估
  • 批准号:
    6949710
  • 财政年份:
    2001
  • 资助金额:
    $ 10.66万
  • 项目类别:

相似海外基金

ARE COMMONLY USED CARDIOVASCULAR RISK SCORING TOOLS RELIABLE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)?
常用的心血管风险评分工具对于慢性阻塞性肺疾病 (COPD) 患者可靠吗?
  • 批准号:
    493118
  • 财政年份:
    2023
  • 资助金额:
    $ 10.66万
  • 项目类别:
Decoding how the aryl hydrocarbon receptor (AhR) controls cigarette smoke-induced lung inflammation and development of chronic obstructive pulmonary disease (COPD)
解读芳烃受体 (AhR) 如何控制香烟烟雾引起的肺部炎症和慢性阻塞性肺病 (COPD) 的发展
  • 批准号:
    487508
  • 财政年份:
    2023
  • 资助金额:
    $ 10.66万
  • 项目类别:
    Operating Grants
The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在慢性阻塞性肺病(COPD)线粒体功能相关衰老中的作用
  • 批准号:
    10633608
  • 财政年份:
    2023
  • 资助金额:
    $ 10.66万
  • 项目类别:
Optimisation of precision therapy for chronic obstructive pulmonary disease: A dynamic treatment regime analysis
慢性阻塞性肺疾病精准治疗优化:动态治疗方案分析
  • 批准号:
    489950
  • 财政年份:
    2023
  • 资助金额:
    $ 10.66万
  • 项目类别:
    Operating Grants
Elucidation of the mechanism of sarcopenia associated with chronic obstructive pulmonary disease
阐明肌肉减少症与慢性阻塞性肺疾病相关的机制
  • 批准号:
    23K15702
  • 财政年份:
    2023
  • 资助金额:
    $ 10.66万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Risk factors for chronic obstructive pulmonary disease exacerbations, quality of care, and outcomes in people with HIV
HIV 感染者慢性阻塞性肺病恶化的危险因素、护理质量和结果
  • 批准号:
    10700228
  • 财政年份:
    2023
  • 资助金额:
    $ 10.66万
  • 项目类别:
Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease
肺炎球菌抗体功能受损和慢性阻塞性肺疾病恶化
  • 批准号:
    10543560
  • 财政年份:
    2022
  • 资助金额:
    $ 10.66万
  • 项目类别:
Pulmonary Vascular Disease as a Contributor to Respiratory Morbidity in Chronic Obstructive Pulmonary Disease
肺血管疾病是慢性阻塞性肺疾病呼吸系统疾病发病的一个原因
  • 批准号:
    10449417
  • 财政年份:
    2022
  • 资助金额:
    $ 10.66万
  • 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations_Supplement
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测_补充
  • 批准号:
    10772527
  • 财政年份:
    2022
  • 资助金额:
    $ 10.66万
  • 项目类别:
Fungal Translocation in Chronic Obstructive Pulmonary Disease
慢性阻塞性肺疾病中的真菌移位
  • 批准号:
    10610446
  • 财政年份:
    2022
  • 资助金额:
    $ 10.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了